Agonistic anti-OX40 monoclonal antibody MEDI6469 Uses, Dosage, Side Effects and more
Agonistic anti-OX40 monoclonal antibody MEDI6469 is a monoclonal antibody under investigation in clinical trial NCT02205333 (A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies).
| Attribute | Details |
|---|---|
| Trade Name | Agonistic anti-OX40 monoclonal antibody MEDI6469 |
| Generic | MEDI-6469 |
| MEDI-6469 Other Names | Agonistic anti-OX40 monoclonal antibody MEDI6469 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
